论文部分内容阅读
直接冠状动脉介入术(PCI)治疗ST段抬高心肌梗死(STEMI)已取得显著疗效,而且有研究显示直接PCI治疗优于溶栓治疗。但是即使成功实行了直接介入治疗及时开通罪犯血管,还是存在再发生心脏事件的危险性。因此,对接受直接PCI治疗的STEMI患者进行恰当的危险评估可以指导临床治疗,加强患者的后期管理,以进一步降低恶性心脏事件的发生率。本文着重讨论目前研究的几个危险分层指标及预后预测因子。
Direct coronary intervention (PCI) in the treatment of ST-elevation myocardial infarction (STEMI) has achieved remarkable results, and studies have shown that direct PCI is superior to thrombolytic therapy. However, even if the successful implementation of direct interventional treatment promptly opened criminals vessels, there is still the risk of re-occurrence of cardiac events. Therefore, proper risk assessment of STEMI patients undergoing direct PCI can guide clinical treatment and enhance post-management of patients to further reduce the incidence of malignant cardiac events. This article focuses on the current study of several risk stratification indicators and predictors of prognosis.